Clast (montelukast) coated tablets 10 mg. №28


Manufacturer: Turkey



Additional treatment of bronchial asthma in patients with persistent mild to moderate asthma, which is insufficiently controlled by inhaled GCS, as well as with insufficient clinical control of asthma using short-acting β-agonists, used if necessary. Symptomatic treatment of seasonal allergic rhinitis in patients with bronchial asthma.

Prevention of asthma, the dominant component of which is bronchospasm induced by physical exertion.

Relief of symptoms of seasonal and year-round allergic rhinitis.